Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Unit 1/Chancellor Court , Suite 335, Guildford, GU2 7AB, GB
Welcomes Brian Riley as President and Chief Technical Officer, Joanne Lager, MD as Chief Medical Officer, and Adrian Chaisson as Chief of Staff.
By: Charlie Sternberg
Villain offers extensive expertise in peptide and oligonucleotide development and manufacturing.
Is purpose-built for manufacturing high-quality plasmid DNA and viral vectors.
Partnership expected to improve yield and upgrade analytical methods ahead of clinical use and regulatory submissions.
This integrated solution follows the company’s acquisition of Pharmacontrol Electronic and combines technologies.
By: Rachel Klemovitch
Released By Upperton
Aim to develop a scalable, end-to-end automated platform for autologous CAR-T cell manufacturing using Cellular Origins’ automated robotics platform.
The extended plans include 26,000 square feet of drug substance manufacturing suites, laboratories, storage, dispensing, and warehousing.
60,500 sq.-ft. manufacturing facility offers capacities for both CDMO and packaging operations.
The expansion will add 9,000 square feet to its Massachusetts facility, expanding development and production capabilities.
Will support spray drying and unit operations including granulation, encapsulation, compression and coating for oral dosage forms.
The company opened a new GMP Pilot Unit to produce liquid and lyophilized injectable forms.
Glycovax has refined its production to meet regulatory requirements and will market the protein through its subsidiary Espoir Therapeutics.
Investment enables GL CHEMTEC to provide preclinical and first-in-human offerings.
This adds to BioDlink's portfolio of international GMP approvals, following recent certifications in Brazil, Indonesia, Egypt, and Colombia.
Makes strategic investments in injectable packaging and cold chain capabilities in the U.S. and Europe.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
